Telik (TELK) Resumes Trading, Up 73%
Tweet Send to a Friend
Telik Inc. (NASDAQ: TELK) has resumed trading following the volatility trading halt and is now up 73% to $2.51. The company was granted orphan drug status for Telintra for myelodysplastic syndrome.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Highway Holdings (HIHO) Halted Again on Circuit Breaker; Last Up 80%
- Investors Brace for Epic Herbalife (HLF) Short Squeeze
- Blue Wolf Mongolia (MNGL), Li3 Energy (LIEG) to Merge
Create E-mail Alert Related Categories
Trading Halts
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
